Max Robotics — Global Service Robot Directory + US Certification

About

Marco Farsi is a leading figure in the advancement of minimally invasive pancreatic and hepatobiliary surgery, with a particular focus on robotic-assisted techniques. His research centers on improving surgical outcomes for complex malignancies, including pancreatic cancer and hepatocellular carcinoma. Dr. Farsi’s major contributions include demonstrating the clinical safety and oncological adequacy of robot-assisted pancreatic surgery, as evidenced by his landmark studies on robotic pancreatoduodenectomy and distal pancreatectomy. His work on robotic enucleations of benign or low-grade pancreatic tumors has also expanded the range of minimally invasive options, reducing the need for demolitive resections. With key papers accumulating over 100 citations, his impact is clear, particularly his 2015 study on minimally invasive approaches to pancreatic malignancies (24 citations) and his 2016 initial experience with robotic pancreatic surgery (19 citations). Notably, his propensity score-matched comparison of robotic versus open pancreatoduodenectomy provides critical evidence for the benefits of robotic surgery, while his work on robotic liver resection for hepatocellular carcinoma further underscores his role in broadening the application of minimally invasive techniques in challenging oncological settings.